Registration now open for BOS Events 2026!

Dates for BOS Events 2026 are 30th June to 1st July for BOS Basel 2026, and 24th and 25th November for BOS Manchester 2026. Please find further details outlining floor plans and pricing options at the event links provided.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Featured Company (BOS Basel 2026)

Enzymaster Deutschland GmbH
Enzymaster provides end-to-end solutions for the development and industrial implementation of innovative, sustainable biocatalytic processes.

Combining AI-guided and computer aided enzyme discovery and enzyme engineering through the BioEngine® platform and the BioNavigator® toolbox, and large-scale...
View profile

Featured Speaker (BOS Basel 2026)

Solid Form Approaches to Screening and Crystallization Development of Peptides

Dr Richard Edwards, Senior Scientist, Veranova

ABSTRACT: Peptides occupy a niche position in the pharmaceutical space, between small molecules and biologics. Routes to purify peptides typically involve costly column chromatography and isolation is often via lyophilisation as an amorphous form. In this talk, we discuss a solid form approach to peptide purification and isolation through the use of crystallisation. Screening and crystallisation workflows are discussed with supporting data from a case study on the glycopeptide, Vancomycin. Advantages of peptide crystallisation are demonstrated including form control, defined particle attributes, impurity... Click here to Read More